Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger J Pomerantz

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2001
Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradicationRoger J Pomerantz
DNA and Cell Biology|May 15, 2004
Effects of HIV-1 Vpr on neuroinvasion and neuropathogenesisRoger J Pomerantz
Archivum Immunologiae Et Therapiae Experimentalis|December 4, 2004
RNA interference:a potential novel therapeutic combating HIV-1 in the central nervous systemRoger J Pomerantz
Archivum Immunologiae Et Therapiae Experimentalis|October 28, 2004
Ludwik Hirszfeld Memorial Lecture: HIV-1 reservoirs: major molecular obstacles to viral eradicationRoger J Pomerantz
Current Opinion in Investigational Drugs (London, England : 2000)|September 5, 2002
Eliminating HIV-1 reservoirsRoger J Pomerantz
HIV Clinical Trials|April 3, 2003
Reservoirs, sanctuaries, and residual disease: the hiding spots of HIV-1Roger J Pomerantz
Clinics in Laboratory Medicine|September 25, 2002
HIV-1 reservoirsRoger J Pomerantz
Expert Opinion on Biological Therapy|November 1, 2005
IL-7 as a potential therapy for HIV-1-infected individualsGiuseppe Nunnari, Roger J Pomerantz
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2002
Approaching eradication of highly active antiretroviral therapy-persistent human immunodeficiency virus type 1 reservoirs with immune activation therapyJoseph Kulkosky, Roger J Pomerantz
Nature Medicine|July 2, 2003
Twenty years of therapy for HIV-1 infectionRoger J Pomerantz, David L Horn
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2001
Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradicationRoger J Pomerantz
DNA and Cell Biology|May 15, 2004
Effects of HIV-1 Vpr on neuroinvasion and neuropathogenesisRoger J Pomerantz
Archivum Immunologiae Et Therapiae Experimentalis|December 4, 2004
RNA interference:a potential novel therapeutic combating HIV-1 in the central nervous systemRoger J Pomerantz
Archivum Immunologiae Et Therapiae Experimentalis|October 28, 2004
Ludwik Hirszfeld Memorial Lecture: HIV-1 reservoirs: major molecular obstacles to viral eradicationRoger J Pomerantz
Current Opinion in Investigational Drugs (London, England : 2000)|September 5, 2002
Eliminating HIV-1 reservoirsRoger J Pomerantz
HIV Clinical Trials|April 3, 2003
Reservoirs, sanctuaries, and residual disease: the hiding spots of HIV-1Roger J Pomerantz
Clinics in Laboratory Medicine|September 25, 2002
HIV-1 reservoirsRoger J Pomerantz
Expert Opinion on Biological Therapy|November 1, 2005
IL-7 as a potential therapy for HIV-1-infected individualsGiuseppe Nunnari, Roger J Pomerantz
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2002
Approaching eradication of highly active antiretroviral therapy-persistent human immunodeficiency virus type 1 reservoirs with immune activation therapyJoseph Kulkosky, Roger J Pomerantz
Nature Medicine|July 2, 2003
Twenty years of therapy for HIV-1 infectionRoger J Pomerantz, David L Horn
Pageof 9